Literature DB >> 19850771

Chronic calcineurin inhibitor nephrotoxicity: reflections on an evolving paradigm.

Robert S Gaston1.   

Abstract

Use of the calcineurin inhibitors (CNI) cyclosporine and tacrolimus has revolutionized solid organ transplantation. For more than 30 yr, the transplant community has dealt with nephrotoxicity attributed to these agents. Acute renal vasoconstriction (as described by many investigators, including John Curtis and colleagues) is the unequivocal consequence of their use; chronic CNI nephropathy, although indistinct in terms of histology and pathophysiology, has become accepted as a major cause of late kidney allograft failure. This article examines clinical, laboratory, and histologic findings that evolved into a paradigm that was never fully consistent with observed outcomes and new evidence that may offer an alternative interpretation for adverse events that are attributed to CNI nephrotoxicity in kidney transplant recipients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19850771     DOI: 10.2215/CJN.03820609

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  34 in total

Review 1.  The impact of donor-specific anti-HLA antibodies on late kidney allograft failure.

Authors:  Alexandre Loupy; Gary S Hill; Stanley C Jordan
Journal:  Nat Rev Nephrol       Date:  2012-04-17       Impact factor: 28.314

2.  Gq signaling causes glomerular injury by activating TRPC6.

Authors:  Liming Wang; Grant Jirka; Paul B Rosenberg; Anne F Buckley; Jose A Gomez; Timothy A Fields; Michelle P Winn; Robert F Spurney
Journal:  J Clin Invest       Date:  2015-04-06       Impact factor: 14.808

3.  Belatacept-Resistant Rejection Is Associated With CD28+ Memory CD8 T Cells.

Authors:  D V Mathews; W C Wakwe; S C Kim; M C Lowe; C Breeden; M E Roberts; A B Farris; E A Strobert; J B Jenkins; C P Larsen; M L Ford; R Townsend; A B Adams
Journal:  Am J Transplant       Date:  2017-07-11       Impact factor: 8.086

Review 4.  Complement as a multifaceted modulator of kidney transplant injury.

Authors:  Paolo Cravedi; Peter S Heeger
Journal:  J Clin Invest       Date:  2014-06-02       Impact factor: 14.808

5.  Chronic progressive calcineurin nephrotoxicity: an overstated concept.

Authors:  Arthur J Matas
Journal:  Am J Transplant       Date:  2011-04       Impact factor: 8.086

6.  Calcineurin (CN) activation promotes apoptosis of glomerular podocytes both in vitro and in vivo.

Authors:  Liming Wang; Jae-Hyung Chang; Seung-Yeol Paik; Yuping Tang; William Eisner; Robert F Spurney
Journal:  Mol Endocrinol       Date:  2011-05-26

7.  Epithelial-to-mesenchymal transition predicts cyclosporine nephrotoxicity in renal transplant recipients.

Authors:  Marc Hazzan; Alexandre Hertig; David Buob; Marie-Christine Copin; Christian Noël; Eric Rondeau; Yi-Chun Dubois-Xu
Journal:  J Am Soc Nephrol       Date:  2011-06-30       Impact factor: 10.121

8.  Nox2 and Cyclosporine-Induced Renal Hypoxia.

Authors:  Arjang Djamali; Nancy A Wilson; Elizabeth A Sadowski; Wei Zha; David Niles; Omeed Hafez; Justin R Dorn; Thomas R Mehner; Paul C Grimm; F Michael Hoffmann; Weixiong Zhong; Sean B Fain; Shannon R Reese
Journal:  Transplantation       Date:  2016-06       Impact factor: 4.939

9.  The accuracy of positron emission tomography in the detection of posttransplant lymphoproliferative disorder.

Authors:  Daan Dierickx; Thomas Tousseyn; Annelies Requilé; Raf Verscuren; Xavier Sagaert; Julie Morscio; Iwona Wlodarska; An Herreman; Dirk Kuypers; Johan Van Cleemput; Frederik Nevens; Lieven Dupont; Anne Uyttebroeck; Jacques Pirenne; Christiane De Wolf-Peeters; Gregor Verhoef; Lieselot Brepoels; Olivier Gheysens
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

Review 10.  Twenty years after ACEIs and ARBs: emerging treatment strategies for diabetic nephropathy.

Authors:  Stacy A Johnson; Robert F Spurney
Journal:  Am J Physiol Renal Physiol       Date:  2015-09-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.